SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-145088
Filing Date
2022-05-09
Accepted
2022-05-09 16:52:41
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d228468ds3.htm S-3 157093
2 EX-5.1 d228468dex51.htm EX-5.1 7609
3 EX-23.1 d228468dex231.htm EX-23.1 1529
4 EX-FILING FEES d228468dexfilingfees.htm EX-FILING FEES 15203
5 GRAPHIC g228468dsp29.jpg GRAPHIC 4634
6 GRAPHIC g228468g03p10.jpg GRAPHIC 39748
  Complete submission text file 0001193125-22-145088.txt   237988
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264803 | Film No.: 22905875
SIC: 2834 Pharmaceutical Preparations